Literature DB >> 23220902

Interobserver variability in the CT assessment of honeycombing in the lungs.

Takeyuki Watadani1, Fumikazu Sakai, Takeshi Johkoh, Satoshi Noma, Masanori Akira, Kiminori Fujimoto, Alexander A Bankier, Kyung Soo Lee, Nestor L Müller, Jae-Woo Song, Jai-Soung Park, David A Lynch, David M Hansell, Martine Remy-Jardin, Tomás Franquet, Yukihiko Sugiyama.   

Abstract

PURPOSE: To quantify observer agreement and analyze causes of disagreement in identifying honeycombing at chest computed tomography (CT).
MATERIALS AND METHODS: The institutional review board approved this multiinstitutional HIPAA-compliant retrospective study, and informed patient consent was not required. Five core study members scored 80 CT images with a five-point scale (5 = definitely yes to 1 = definitely no) to establish a reference standard for the identification of honeycombing. Forty-three observers from various subspecialties and geographic regions scored the CT images by using the same scoring system. Weighted κ values of honeycombing scores compared with the reference standard were analyzed to investigate intergroup differences. Images were divided into four groups to allow analysis of imaging features of cases in which there was disagreement: agreement on the presence of honeycombing, agreement on the absence of honeycombing, disagreement on the presence of honeycombing, and other (none of the preceding three groups applied).
RESULTS: Agreement of scores of honeycombing presence by 43 observers with the reference standard was moderate (Cohen weighted κ values: 0.40-0.58). There were no significant differences in κ values among groups defined by either subspecialty or geographic region (Tukey-Kramer test, P = .38 to >.99). In 29% of cases, there was disagreement on identification of honeycombing. These cases included honeycombing mixed with traction bronchiectasis, large cysts, and superimposed pulmonary emphysema.
CONCLUSION: Identification of honeycombing at CT is subjective, and disagreement is largely caused by conditions that mimic honeycombing.

Entities:  

Mesh:

Year:  2012        PMID: 23220902     DOI: 10.1148/radiol.12112516

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  90 in total

1.  Quantitative computed tomography detects interstitial lung diseases proven by biopsy.

Authors:  Alarico Ariani; Andrea Imperatori; Massimo Castiglioni; Elisa Daffrè; Marina Aiello; Giuseppina Bertorelli; Alfredo Chetta; Lorenzo Dominioni; Nicola Rotolo
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

2.  MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis.

Authors:  Susan K Mathai; Stephen Humphries; Jonathan A Kropski; Timothy S Blackwell; Julia Powers; Avram D Walts; Cheryl Markin; Julia Woodward; Jonathan H Chung; Kevin K Brown; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha Fingerlin; Ivana V Yang; David A Lynch; David A Schwartz
Journal:  Thorax       Date:  2019-09-26       Impact factor: 9.139

3.  Feasibility of low-dose CT with spectral shaping and third-generation iterative reconstruction in evaluating interstitial lung diseases associated with connective tissue disease: an intra-individual comparison study.

Authors:  Xiaoli Xu; Xin Sui; Lan Song; Yao Huang; Yingqian Ge; Zhengyu Jin; Wei Song
Journal:  Eur Radiol       Date:  2019-02-08       Impact factor: 5.315

4.  Volume-related structures predict UIP pathology in those with a non-IPF pattern on CT.

Authors:  Jonathan H Chung; Ayodeji Adegunsoye; Justin M Oldham; Rekha Vij; Aliya Husain; Steven M Montner; Ronald A Karwoski; Brian J Bartholmai; Mary E Strek
Journal:  Eur Radiol       Date:  2021-04-13       Impact factor: 5.315

5.  A content-boosted collaborative filtering algorithm for personalized training in interpretation of radiological imaging.

Authors:  Hongli Lin; Xuedong Yang; Weisheng Wang
Journal:  J Digit Imaging       Date:  2014-08       Impact factor: 4.056

6.  Outcome Measures for Clinical Trials in Interstitial Lung Diseases.

Authors:  Matthew R Lammi; Robert P Baughman; Surinder S Birring; Anne-Marie Russell; Jay H Ryu; Marybeth Scholand; Oliver Distler; Daphne LeSage; Catherine Sarver; Katerina Antoniou; Kristin B Highland; Otylia Kowal-Bielecka; Joseph A Lasky; Athol U Wells; Lesley Ann Saketkoo
Journal:  Curr Respir Med Rev       Date:  2015

7.  Pulmonary fibrosis and emphysema: Is the emphysema type associated with the pattern of fibrosis?

Authors:  Anastasia Oikonomou; Paraskevi Mintzopoulou; Argyris Tzouvelekis; Petros Zezos; George Zacharis; Anastasios Koutsopoulos; Demosthenes Bouros; Panos Prassopoulos
Journal:  World J Radiol       Date:  2015-09-28

8.  Endobronchial Optical Coherence Tomography for Low-Risk Microscopic Assessment and Diagnosis of Idiopathic Pulmonary Fibrosis In Vivo.

Authors:  Lida P Hariri; David C Adams; John C Wain; Michael Lanuti; Ashok Muniappan; Amita Sharma; Thomas V Colby; Mari Mino-Kenudson; Eugene J Mark; Richard L Kradin; Hannah Goulart; Andrew M Tager; Melissa J Suter
Journal:  Am J Respir Crit Care Med       Date:  2018-04-01       Impact factor: 21.405

9.  Prediction of survival by texture-based automated quantitative assessment of regional disease patterns on CT in idiopathic pulmonary fibrosis.

Authors:  Sang Min Lee; Joon Beom Seo; Sang Young Oh; Tae Hoon Kim; Jin Woo Song; Sang Min Lee; Namkug Kim
Journal:  Eur Radiol       Date:  2017-09-19       Impact factor: 5.315

10.  [Mesenchymal abdominal tumors].

Authors:  T Helmberger
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.